Cargando…

Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing

One key application of organ-on-chip systems is the examination of drug transport and absorption through native cell barriers such the blood–brain barrier. To overcome previous hurdles related to the transferability of existing static cell cultivation protocols and polydimethylsiloxane (PDMS) as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Eugen V., Ledwig, Verena, Bendas, Sebastian, Reichl, Stephan, Dietzel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323870/
https://www.ncbi.nlm.nih.gov/pubmed/35890346
http://dx.doi.org/10.3390/pharmaceutics14071451
_version_ 1784756664103075840
author Koch, Eugen V.
Ledwig, Verena
Bendas, Sebastian
Reichl, Stephan
Dietzel, Andreas
author_facet Koch, Eugen V.
Ledwig, Verena
Bendas, Sebastian
Reichl, Stephan
Dietzel, Andreas
author_sort Koch, Eugen V.
collection PubMed
description One key application of organ-on-chip systems is the examination of drug transport and absorption through native cell barriers such the blood–brain barrier. To overcome previous hurdles related to the transferability of existing static cell cultivation protocols and polydimethylsiloxane (PDMS) as the construction material, a chip platform with key innovations for practical use in drug-permeation testing is presented. First, the design allows for the transfer of barrier-forming tissue into the microfluidic system after cells have been seeded on porous polymer or Si3N4 membranes. From this, we can follow highly reproducible models and cultivation protocols established for static drug testing, from coating the membrane to seeding the cells and cell analysis. Second, the perfusion system is a microscopable glass chip with two fluid compartments with transparent embedded electrodes separated by the membrane. The reversible closure in a clamping adapter requires only a very thin PDMS sealing with negligible liquid contact, thereby eliminating well-known disadvantages of PDMS, such as its limited usability in the quantitative measurements of hydrophobic drug molecule concentrations. Equipped with tissue transfer capabilities, perfusion chamber inertness and air bubble trapping, and supplemented with automated fluid control, the presented system is a promising platform for studying established in vitro models of tissue barriers under reproducible microfluidic perfusion conditions.
format Online
Article
Text
id pubmed-9323870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93238702022-07-27 Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing Koch, Eugen V. Ledwig, Verena Bendas, Sebastian Reichl, Stephan Dietzel, Andreas Pharmaceutics Article One key application of organ-on-chip systems is the examination of drug transport and absorption through native cell barriers such the blood–brain barrier. To overcome previous hurdles related to the transferability of existing static cell cultivation protocols and polydimethylsiloxane (PDMS) as the construction material, a chip platform with key innovations for practical use in drug-permeation testing is presented. First, the design allows for the transfer of barrier-forming tissue into the microfluidic system after cells have been seeded on porous polymer or Si3N4 membranes. From this, we can follow highly reproducible models and cultivation protocols established for static drug testing, from coating the membrane to seeding the cells and cell analysis. Second, the perfusion system is a microscopable glass chip with two fluid compartments with transparent embedded electrodes separated by the membrane. The reversible closure in a clamping adapter requires only a very thin PDMS sealing with negligible liquid contact, thereby eliminating well-known disadvantages of PDMS, such as its limited usability in the quantitative measurements of hydrophobic drug molecule concentrations. Equipped with tissue transfer capabilities, perfusion chamber inertness and air bubble trapping, and supplemented with automated fluid control, the presented system is a promising platform for studying established in vitro models of tissue barriers under reproducible microfluidic perfusion conditions. MDPI 2022-07-12 /pmc/articles/PMC9323870/ /pubmed/35890346 http://dx.doi.org/10.3390/pharmaceutics14071451 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Koch, Eugen V.
Ledwig, Verena
Bendas, Sebastian
Reichl, Stephan
Dietzel, Andreas
Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title_full Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title_fullStr Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title_full_unstemmed Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title_short Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
title_sort tissue barrier-on-chip: a technology for reproducible practice in drug testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323870/
https://www.ncbi.nlm.nih.gov/pubmed/35890346
http://dx.doi.org/10.3390/pharmaceutics14071451
work_keys_str_mv AT kocheugenv tissuebarrieronchipatechnologyforreproduciblepracticeindrugtesting
AT ledwigverena tissuebarrieronchipatechnologyforreproduciblepracticeindrugtesting
AT bendassebastian tissuebarrieronchipatechnologyforreproduciblepracticeindrugtesting
AT reichlstephan tissuebarrieronchipatechnologyforreproduciblepracticeindrugtesting
AT dietzelandreas tissuebarrieronchipatechnologyforreproduciblepracticeindrugtesting